New Delhi, 11 Jan 2025: The Central Drugs Standard Control Organisation’s (CDSCO’s) draft rules for re-classification of medical devices based on their risk profile has received wide support from the industry, as it will allow centralaised, faster approval of high-ris......
View Details

Related News

• Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)

---

• Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)

---

• FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)

---

• Dabur sues Patanjali over toothpaste trade dress (16-01-2025)

---

• Wrappers of drug brands found from Paonta printing press premises (16-01-2025)

---

• PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)

---

• Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)

---

• Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)

---

• SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)

---

• 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)

---